These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 15876933)
1. Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations. Tan T; Halperin S; Cherry JD; Edwards K; Englund JA; Glezen P; Greenberg D; Rothstein E; Skowronski D Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S83-6. PubMed ID: 15876933 [TBL] [Abstract][Full Text] [Related]
2. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations. Forsyth K; Nagai M; Lepetic A; Trindade E Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S93-7. PubMed ID: 15876935 [TBL] [Abstract][Full Text] [Related]
3. Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations. Wirsing von König CH; Campins-Marti M; Finn A; Guiso N; Mertsola J; Liese J Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S87-92. PubMed ID: 15876934 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology of pertussis. Tan T; Trindade E; Skowronski D Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S10-8. PubMed ID: 15876918 [TBL] [Abstract][Full Text] [Related]
5. The global pertussis initiative: process overview. Plotkin S Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S7-9. PubMed ID: 15876931 [TBL] [Abstract][Full Text] [Related]
6. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
7. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV; MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217 [TBL] [Abstract][Full Text] [Related]
8. Pertussis sources of infection and routes of transmission in the vaccination era. Schellekens J; von König CH; Gardner P Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S19-24. PubMed ID: 15876919 [TBL] [Abstract][Full Text] [Related]
9. Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults. Scott LJ BioDrugs; 2010 Dec; 24(6):387-406. PubMed ID: 21043546 [TBL] [Abstract][Full Text] [Related]
10. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A; Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665 [TBL] [Abstract][Full Text] [Related]
11. Pertussis in adolescents and adults: should we vaccinate? Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232 [TBL] [Abstract][Full Text] [Related]
12. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis. Wilson TR J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630 [TBL] [Abstract][Full Text] [Related]
13. [Immunization of adolescents and adults as the strategy of improvement of epidemiology of pertussis]. Lutyńska A; Wiatrzyk A; Mosiej E; Zawadka M Przegl Epidemiol; 2011; 65(1):45-50. PubMed ID: 21735835 [TBL] [Abstract][Full Text] [Related]
14. Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update. Forsyth KD; Tan T; von König CW; Heininger U; Chitkara AJ; Plotkin S Vaccine; 2018 Nov; 36(48):7270-7275. PubMed ID: 30337176 [TBL] [Abstract][Full Text] [Related]
15. Economic burden of pertussis and the impact of immunization. Caro JJ; Getsios D; Payne K; Annemans L; Neumann PJ; Trindade E Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S48-54. PubMed ID: 15876924 [TBL] [Abstract][Full Text] [Related]
16. Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US. Plosker GL BioDrugs; 2009; 23(4):253-67. PubMed ID: 19697967 [TBL] [Abstract][Full Text] [Related]
17. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR; Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582 [TBL] [Abstract][Full Text] [Related]
18. Boostrix: a reduced-dose acellular pertussis vaccine for use in adolescents and adults. Li WC; Wu TZ; Huang YC; Huang LM Expert Rev Vaccines; 2009 Oct; 8(10):1317-27. PubMed ID: 19803753 [TBL] [Abstract][Full Text] [Related]
19. Pertussis-the case for universal vaccination. Rittle C J Spec Pediatr Nurs; 2010 Oct; 15(4):282-91. PubMed ID: 20880276 [TBL] [Abstract][Full Text] [Related]
20. [Old problems and new strategies in the fight against pertussis]. Carlino C; Zaratti L; Franco E Ig Sanita Pubbl; 2013; 69(4):473-80. PubMed ID: 24091847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]